Bob Still, executive director of the Radiologist Business Management Association, believes CMS’s proposed physician fee schedule for 2023 will harm vulnerable populations and seriously injure U.S. healthcare. Hear him out.

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology. 

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.

Within hours of Amazon announcing its intention to acquire healthcare provider One Medical for $3.9 billion in cash, lawmakers took aim at the retail giant to pursue blocking the deal.

Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals. 

Defendants in the case allegedly defrauded CMS for millions of dollars that were spent on luxury vehicles, real estate and more.

Two weeks ago CMS proposed a 2023 physician fee schedule (PFS) that stands to slash pay to U.S. diagnostic radiologists by 3% and interventionalists by 4%. This week the U.K.’s National Health Service put that country’s radiologists in a similar bind.